Cargando…

Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening

BACKGROUND: Internationally, most atrial fibrillation (AF) management guidelines recommend opportunistic screening for AF in people ≥65 years of age and oral anticoagulant treatment for those at high stroke risk (CHA₂DS₂‐VA≥2). However, gaps remain in screening and treatment. METHODS AND RESULTS: Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Orchard, Jessica, Li, Jialin, Freedman, Ben, Webster, Ruth, Salkeld, Glenn, Hespe, Charlotte, Gallagher, Robyn, Patel, Anushka, Kamel, Bishoy, Neubeck, Lis, Lowres, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726973/
https://www.ncbi.nlm.nih.gov/pubmed/32865129
http://dx.doi.org/10.1161/JAHA.120.017080
_version_ 1783620999383613440
author Orchard, Jessica
Li, Jialin
Freedman, Ben
Webster, Ruth
Salkeld, Glenn
Hespe, Charlotte
Gallagher, Robyn
Patel, Anushka
Kamel, Bishoy
Neubeck, Lis
Lowres, Nicole
author_facet Orchard, Jessica
Li, Jialin
Freedman, Ben
Webster, Ruth
Salkeld, Glenn
Hespe, Charlotte
Gallagher, Robyn
Patel, Anushka
Kamel, Bishoy
Neubeck, Lis
Lowres, Nicole
author_sort Orchard, Jessica
collection PubMed
description BACKGROUND: Internationally, most atrial fibrillation (AF) management guidelines recommend opportunistic screening for AF in people ≥65 years of age and oral anticoagulant treatment for those at high stroke risk (CHA₂DS₂‐VA≥2). However, gaps remain in screening and treatment. METHODS AND RESULTS: General practitioners/nurses at practices in rural Australia (n=8) screened eligible patients (≥65 years of age without AF) using a smartphone ECG during practice visits. eHealth tools included electronic prompts, guideline‐based electronic decision support, and regular data reports. Clinical audit tools extracted de‐identified data. Results were compared with an earlier study in metropolitan practices (n=8) and nonrandomized control practices (n=69). Cost‐effectiveness analysis compared population‐based screening with no screening and included screening, treatment, and hospitalization costs for stroke and serious bleeding events. Patients (n=3103, 34%) were screened (mean age, 75.1±6.8 years; 47% men) and 36 (1.2%) new AF cases were confirmed (mean age, 77.0 years; 64% men; mean CHA₂DS₂‐VA, 3.2). Oral anticoagulant treatment rates for patients with CHA₂DS₂‐VA≥2 were 82% (screen detected) versus 74% (preexisting AF)(P=NS), similar to metropolitan and nonrandomized control practices. The incremental cost‐effectiveness ratio for population‐based screening was AU$16 578 per quality‐adjusted life year gained and AU$84 383 per stroke prevented compared with no screening. National implementation would prevent 147 strokes per year. Increasing the proportion screened to 75% would prevent 177 additional strokes per year. CONCLUSIONS: An AF screening program in rural practices, supported by eHealth tools, screened 34% of eligible patients and was cost‐effective. Oral anticoagulant treatment rates were relatively high at baseline, trending upward during the study. Increasing the proportion screened would prevent many more strokes with minimal incremental cost‐effectiveness ratio change. eHealth tools, including data reports, may be a valuable addition to future programs. REGISTRATION: URL: https://www.anzctr.org.au. Unique identifier: ACTRN12618000004268.
format Online
Article
Text
id pubmed-7726973
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77269732020-12-13 Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening Orchard, Jessica Li, Jialin Freedman, Ben Webster, Ruth Salkeld, Glenn Hespe, Charlotte Gallagher, Robyn Patel, Anushka Kamel, Bishoy Neubeck, Lis Lowres, Nicole J Am Heart Assoc Original Research BACKGROUND: Internationally, most atrial fibrillation (AF) management guidelines recommend opportunistic screening for AF in people ≥65 years of age and oral anticoagulant treatment for those at high stroke risk (CHA₂DS₂‐VA≥2). However, gaps remain in screening and treatment. METHODS AND RESULTS: General practitioners/nurses at practices in rural Australia (n=8) screened eligible patients (≥65 years of age without AF) using a smartphone ECG during practice visits. eHealth tools included electronic prompts, guideline‐based electronic decision support, and regular data reports. Clinical audit tools extracted de‐identified data. Results were compared with an earlier study in metropolitan practices (n=8) and nonrandomized control practices (n=69). Cost‐effectiveness analysis compared population‐based screening with no screening and included screening, treatment, and hospitalization costs for stroke and serious bleeding events. Patients (n=3103, 34%) were screened (mean age, 75.1±6.8 years; 47% men) and 36 (1.2%) new AF cases were confirmed (mean age, 77.0 years; 64% men; mean CHA₂DS₂‐VA, 3.2). Oral anticoagulant treatment rates for patients with CHA₂DS₂‐VA≥2 were 82% (screen detected) versus 74% (preexisting AF)(P=NS), similar to metropolitan and nonrandomized control practices. The incremental cost‐effectiveness ratio for population‐based screening was AU$16 578 per quality‐adjusted life year gained and AU$84 383 per stroke prevented compared with no screening. National implementation would prevent 147 strokes per year. Increasing the proportion screened to 75% would prevent 177 additional strokes per year. CONCLUSIONS: An AF screening program in rural practices, supported by eHealth tools, screened 34% of eligible patients and was cost‐effective. Oral anticoagulant treatment rates were relatively high at baseline, trending upward during the study. Increasing the proportion screened would prevent many more strokes with minimal incremental cost‐effectiveness ratio change. eHealth tools, including data reports, may be a valuable addition to future programs. REGISTRATION: URL: https://www.anzctr.org.au. Unique identifier: ACTRN12618000004268. John Wiley and Sons Inc. 2020-08-31 /pmc/articles/PMC7726973/ /pubmed/32865129 http://dx.doi.org/10.1161/JAHA.120.017080 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Orchard, Jessica
Li, Jialin
Freedman, Ben
Webster, Ruth
Salkeld, Glenn
Hespe, Charlotte
Gallagher, Robyn
Patel, Anushka
Kamel, Bishoy
Neubeck, Lis
Lowres, Nicole
Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
title Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
title_full Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
title_fullStr Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
title_full_unstemmed Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
title_short Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening
title_sort atrial fibrillation screen, management, and guideline‐recommended therapy in the rural primary care setting: a cross‐sectional study and cost‐effectiveness analysis of ehealth tools to support all stages of screening
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726973/
https://www.ncbi.nlm.nih.gov/pubmed/32865129
http://dx.doi.org/10.1161/JAHA.120.017080
work_keys_str_mv AT orchardjessica atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT lijialin atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT freedmanben atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT websterruth atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT salkeldglenn atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT hespecharlotte atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT gallagherrobyn atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT patelanushka atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT kamelbishoy atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT neubecklis atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening
AT lowresnicole atrialfibrillationscreenmanagementandguidelinerecommendedtherapyintheruralprimarycaresettingacrosssectionalstudyandcosteffectivenessanalysisofehealthtoolstosupportallstagesofscreening